Effects of colestimide in addition to atorvastatin on low-density lipoprotein (LDL) cholesterol in patients with heterozygous familial hypercholesterolemia (FH)

被引:0
|
作者
Kawashiri, M [1 ]
Higashikata, T [1 ]
Tsuchida, M [1 ]
Takata, M [1 ]
Katsuda, S [1 ]
Miwa, K [1 ]
Inazu, A [1 ]
Mabuchi, H [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 920, Japan
关键词
D O I
10.1016/S1567-5688(03)90741-0
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:172 / 172
页数:1
相关论文
共 50 条
  • [21] Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
    Nenseter, Marit S.
    Narverud, Ingunn
    Graesdal, Asgeir
    Bogsrud, Martin P.
    Aukrust, Pal
    Retterstol, Kjetil
    Ose, Leiv
    Halvorsen, Bente
    Holven, Kirsten B.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (02) : 109 - 116
  • [22] Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia
    Higashikata, T
    Mabuchi, H
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04): : 402 - 407
  • [23] Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
    Sánchez-Quesada, JL
    Otal-Entraigas, C
    Franco, M
    Jorba, O
    González-Sastre, F
    Blanco-Vaca, F
    Ordóñez-Llanos, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06): : 655 - 659
  • [24] CONTRASTING EFFECTS OF LOVASTATIN AND CHOLESTYRAMINE ON LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND 24-HOUR URINARY MEVALONATE EXCRETION IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    PAPPU, AS
    ILLINGWORTH, DR
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1989, 114 (05): : 554 - 562
  • [25] FAMILIAL HYPERCHOLESTEROLEMIA WITH MINIMAL REDUCTION OF LOW-DENSITY LIPOPROTEIN (LDL) RECEPTOR ACTIVITY
    OSTLUND, RE
    LEVY, RA
    WITZTUM, JL
    SCHONFELD, G
    CLINICAL RESEARCH, 1980, 28 (02): : A402 - A402
  • [26] EFFECTS OF COLESTIPOL ON LOW-DENSITY-LIPOPROTEIN IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SUNDBERG, EE
    ILLINGWORTH, DR
    ARTERIOSCLEROSIS, 1987, 7 (05): : A513 - A513
  • [27] The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein(a) levels in familial hypercholesterolemia
    Tonstad, S
    Sundt, E
    Ose, L
    Hagve, TA
    Fruchart, JC
    Bard, JM
    Eden, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (11): : 1415 - 1421
  • [28] MODELLING THE US POPULATION HEALTH BENEFITS OF FURTHER LOW-DENSITY LIPOPROTEIN CHOLESTEROL REDUCTION WITH ALIROCUMAB AMONG ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL
    Sanchez, Robert
    Nasir, Khurram
    Klimchak, Alexa
    Kuznik, Andreas
    Joulain, Florence
    Briggs, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 66 - 66
  • [29] Exploring the Efficacy of Alirocumab and Evolocumab in Reducing Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients With Familial Hypercholesterolemia: A Systematic Review
    Luthra, Gaurav
    Shahbaz, Mahrukh
    Almatooq, Halah
    Foucambert, Paul
    Esbrand, Faith
    Zafar, Sana
    Panthangi, Venkatesh
    Kurupp, Adrienne R. Cyril
    Raju, Anjumol
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [30] THE FATTY-ACID COMPOSITION OF SERUM LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND LYMPHOCYTE CHOLESTEROL ESTERS IN CHILDREN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    ANDERSEN, GE
    JOHANSEN, KB
    ACTA PAEDIATRICA SCANDINAVICA, 1980, 69 (04): : 453 - 455